Shares of Dr Reddy's Laboratories jumped 5.3 per cent on Thursday to Rs 1,217 apiece, making it the top gainer in the Nifty 50 and the BSE 100 indices. By comparison, the Nifty 50 was up 0.53 per cent at 25,289.
Pharma major Dr Reddy's Laboratories delivered a muted operational performance in the fourth quarter of financial year 2024-25 (Q4FY25), even as revenue growth remained healthy. Lower gross margin performance and muted domestic growth are key concerns. Most brokerages have a "Sell" or "Reduce" rating as there are uncertainties related to the development of a new product portfolio and the launch timelines.
Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.
While about 8,000 people are in the long list of invitees, the select list features just a few hundred people, including prominent politicians, leading industrialists, top film stars, sportspersons, bureaucrats and diplomats.
Unhappy with the Question Hour being stretched, Congress MLA Basavaraj Rayareddy said the Speaker should 'tear' the rule book if he is not following it.
Dr Reddy's, which has tied up with Russian Direct Investment Fund for Sputnik V in India, soft launched the vaccine in India in May 2021, after receiving Emergency Use Authorisation in April 2021.
The opposition Congress on Thursday stepped up the attack on the ruling Bharatiya Janata Party in Karnataka and demanded the arrest of party MP Tejasvi Surya and a party MLA, alleging they were behind the scam involving blocking of hospital beds meant for COVID patients in Bengaluru.
The company will supply the drug to major government as well as private hospitals across India, Dr Reddy's said in a regulatory filing.
Pharma firms wants new policies that will boost investment.
Pharma firms wants new policies that will boost investment.
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
Veena Malik to set a record by giving maximum kisses in her forthcoming film.
Traders' body CAIT on Wednesday wrote to Reliance Industries chief Mukesh Ambani and 50 other captains of India Inc, including Ratan Tata, Azim Premji, Gautam Adani, Ajay Piramal, Anand Mahindra and Sunil Bharti Mittal seeking their support in its campaign to boycott Chinese goods. The Confederation of All India Traders (CAIT) also urged Kumar Mangalam Birla, Vikram Kirloskar, Rahul Bajaj, Shiv Nadar, Pallonji Mistry, Uday Kotak, Nusli Wadia, Shashi Ruia, Madhukar Parekh, Harsh Mariwala, Satish Reddy and Pankaj Patel, among other prominent industrialists, to join its 'Bhartiya Samaan-Humaara Abhimaan' campaign.
Pharma major Dr Reddy's Laboratories has opposed the parliamentary Standing committee's recommendations of increasing the number of drugs under price control and cap on profit margins of all medicines.
Drug maker Dr Reddy's Laboratories on Wednesday said it was looking out for partnerships to expand its presence in Japan.
Dr Reddy's Laboratories, the second largest drug maker in the country, would invest about Rs 750 crore.
The ruling party legislators have expressed serious reservations about MLCs not elected by the people being made ministers, lack of representation to certain regions, with most ministers still from Bengaluru and Belagavi districts and also on their 'seniority or sacrifice' not being considered.
Dr Reddy's Laboratories has completed acquisition of betapharm, its mega overseas deal valued at 480 million (Rs 2,668 crore).\n
The US continues to be the most important part of our overseas portfolio
Dr Reddy's Laboratories on Thursday launched diabetic foot ulcers treatment drug, Plermin, for patients who develop food ulcers due to neuropathy.
Jaganmohan Reddy will be sworn in as chief minister on May 30.
Karnataka Chief Minister B S Yediyurappa on Wednesday expanded his 17-month old cabinet, inducting seven ministers, and indicated that excise minister H Nagesh would be dropped. Governor Vajubhai Vala administered the oath of office and secrecy to the ministers at a ceremony at the Raj Bhavan.
The government was hoping to roll out the GST regime from April 2016.
Police had denied permission for the rally but the BJP insisted they would go ahead with the rally plan.
Srikanth Bolla, CEO of Bollant Industries, has set his sights on changing lives
The weekly fashion round-up, where we bring you the latest on supermodels, style, designers and everything in between.
Retracing the journey that brought coffee from Araku Valley in Andhra Pradesh to an upscale caf in the aristocratic district of Le Marais in Paris.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances